Close

Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Opportunities for Zerenex

Go back to Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Opportunities for Zerenex
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) Delayed: 3.36 --0 (-0%)
Previous Close $3.36    52 Week High $7.80 
Open $438.10    52 Week Low $2.80 
Day High $3.36    P/E N/A 
Day Low $3.36    EPS $-0.45 
Volume 1,132,646